An analysis of 1,651 postmenopausal women, some of whom used hormone replacement therapy, found a strong association between fasting insulin levels and breast cancer risk. Researchers say those who had the highest insulin levels had about a 1.5-fold higher risk of developing breast cancer than those with the lowest levels.

Related Summaries